Rachel Reynolds: Newest Preventative Treatments in Skin Cancer

The landscape of skin cancer prevention is rapidly evolving. Beyond sunscreen and routine surveillance, new evidence is reshaping how clinicians identify high-risk patients, reduce cancer risk, and intervene before malignancy develops.

In this timely and practical lecture, Dr. Rachel Reynolds will review the latest advances in skin cancer prevention, including emerging chemopreventive strategies, field cancerization treatments, risk stratification, genetic considerations, and evidence-based approaches for patients with extensive sun damage or a history of skin cancer.

Participants will gain insight into how preventive therapies can reduce the burden of basal cell carcinoma, squamous cell carcinoma, and melanoma, particularly in high-risk populations. The session will also explore the role of dermatologists, surgeons, and primary care providers in creating comprehensive prevention strategies that extend beyond lesion detection and treatment.

As skin cancer incidence continues to rise worldwide, prevention offers one of the greatest opportunities to improve outcomes, reduce healthcare costs, and enhance patient quality of life.

SPEAKER

Rachel V. Reynolds, MD, is Interim Chair of Dermatology at Beth Israel Deaconess Medical Center and Assistant Professor of Dermatology at Harvard Medical School. She completed medical school at the University of Pennsylvania and her dermatology residency through the Harvard Combined Dermatology Program. She practices medical, surgical, and cosmetic dermatology and is recognized nationally for her clinical and educational contributions.

Dr. Reynolds serves in numerous leadership roles within the American Academy of Dermatology and has contributed to national clinical guidelines and educational initiatives. In addition to her expertise in general and surgical dermatology, she has a particular interest in skin cancer detection and the care of high-risk patients.

Her lecture will focus on the practical recognition of head and neck skin cancers and the diagnostic clues that help clinicians identify lesions requiring further investigation and treatment.

Professional Websites

Harvard Health Publishing: https://www.health.harvard.edu/authors/rachel-reynolds-md

Beth Israel Deaconess Medical Center: https://findadoc.bidmc.org/details/1267/rachel-reynolds-dermatology-boston-chestnut_hill-needham

Harvard Catalyst Faculty Profile: https://connects.catalyst.harvard.edu/profiles/display/Person/87938

LEARNING OBJECTIVES

By the end of this event, participants will be able to:

1. Review current trends in skin cancer epidemiology and prevention.

2. Identify patients who may benefit from enhanced preventive strategies.

3. Understand the evidence supporting chemoprevention in high-risk populations.

4. Recognize emerging approaches to field cancerization and precancer treatment.

5. Apply practical prevention strategies in everyday clinical practice.

TARGET AUDIENCE

• Oral and Maxillofacial Surgeons

• Dermatologists

• Plastic Surgeons

• Head & Neck Surgeons

• ENT Surgeons

• Primary Care Physicians

• Residents and Fellows

• Medical and Dental Students

• Advanced Practice Providers

FREE ONLINE LIVE EVENT

San Francisco: Monday, September 28, 2026 at 4:00 pm

Mexico City: Monday, September 28, 2026 at 5:00 pm

New York: Monday, September 28, 2026 at 7:00 pm

Rio de Janeiro: Monday, September 28, 2026 at 8:00 pm

London: Tuesday, September 29, 2026 at 12:00 midnight

Berlin: Tuesday, September 29, 2026 at 1:00 am

Johannesburg: Tuesday, September 29, 2026 at 1:00 am

Cairo: Tuesday, September 29, 2026 at 2:00 am

Dubai: Tuesday, September 29, 2026 at 3:00 am

Delhi: Tuesday, September 29, 2026 at 4:30 am

Manila: Tuesday, September 29, 2026 at 7:00 am

Sydney: Tuesday, September 29, 2026 at 9:00 am

LANGUAGE: The event language is English.

CE ACCREDITATION : surgeON is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. surgeON designates this activity for 1 credit hour of continuing education credits.

DECLARATION

In accordance with criterion 13 of document UEMS 2023.07.rev “EACCME® Criteria for the Accreditation of Live Educational Events (LEEs)” and the Standard v. Commercial or Promotional Conflict of Interest, published by the American Dental Association Continuing Education Recognition Program (ADA CERP), all surgeON presenters sign a Conflict of Interest form to document all perceived or actual conflicts of interest for the last 3 years, whether due to a financial or other relationship. This document can be viewed at the beginning of the event or on request by emailing info@surgeon-events.org No fee, honorarium or arrangement for re-imbursement of expenses in relation to the this event has been provided to the speaker.